Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Business
Henry Saker-Clark

Revenues fall at Sensodyne maker Haleon after weaker painkiller sales

Haleon floated on the London Stock Exchange with a value of more than £30 billion (Haleon/PA) -

Consumer healthcare firm Haleon has revealed a surprise dip in revenues for the latest quarter as it was impacted by weaker sales of painkillers.

Shares in the Sensodyne and Voltaren maker were lower in early trading on Thursday as a result.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.